Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Oct 1;55(2):182–188. doi: 10.1097/QAI.0b013e3181e222c9

Table 1.

Clinical Characteristics of Children with and Without HIV Infection in a Case-Control Study of Biomarkers of Vascular Dysfunction

Variable Controls (n=55) HIV + (n=106) P

Mean (SD) Age, y 12.3 (3.8) 14.8 (4.3) <0.001
Percent female 43 56 0.14
Race, % 0.04
 Black 78 62
 Hispanic 18 24
 White/other 4 15
Mean (SD) Weight z-score 0.55 (1.2) 0.26 (1.3) 0.17
Mean (SD) Height z-score 0.19 (.98) −0.46 (1.2) <0.001
Mean (SD) BMI z-score 0.51 (1.2) 0.51 (1.1) 0.99
Mean (SD) Body fat, % 24 (13)
Mean (SD) Trunk fat, % 24 (14)
Mean (SD) Waist circumference, cm 76 (15)
Mean (SD) Hip circumference, cm 86 (15)
Mean (SD) Waist:hip ratio 0.89 (0.07)
Disease Characteristics
CDC Stage, %
 Stage A 22
 Stage B 34
 Stage C 39
 Stage N 6
Mean (SD) CD4, % 27 (13)
Median [IQR] Viral load 882 [50, 11500]
% Receiving HAART 86
Mean (SD) duration of HAART, y 6.0 (3.1)
% Receiving Protease Inhibitors 80
Mean (SD) duration of PI therapy, y 5.0 (3.3)
% Receiving NRTI 90
Mean (SD) duration of NRTI, y 9.2 (4.6)
% Receiving NNRTI 11
Mean (SD) duration of NNRTI therapy, y 2.3 (2.6)

IQR = interquartile range; HAART = highly active antiretroviral therapy; NRTI = nucleoside reverse transcriptase inhibitor; NNRTI = non-nucleoside reverse transcriptase inhibitor